Literature DB >> 35905470

Barriers to surgical menopause counseling in gynecologic cancers: a quantitative and qualitative study of patients and providers.

Connor C Wang1, Dandi S Huang2, Anisa M Carlson1, Zhanhai Li3, Ahmed Al-Niaimi4, Makeba Williams5.   

Abstract

OBJECTIVE: The objective of this study is to identify factors associated with receiving surgical menopause counseling in gynecologic cancer patients, as well as patient and provider perspectives, regarding surgical menopause counseling and management.
METHODS: We conducted a single-institution mixed-method study combining retrospective chart review and patient and provider surveys. Patients younger than 51 years who experienced surgical menopause after gynecologic cancer treatment from January 2017 to December 2019 were surveyed in April 2021 about experiences with menopause counseling, barriers to care, and quality of life. We then reviewed charts of only patients who fully completed surveys. All gynecologic oncology providers were surveyed about surgical menopause practices. Logistic regression identified factors associated with receiving counseling.
RESULTS: Sixty-six of 75 identified met inclusion criteria and received survey invitations. Thirty-five (53%) completed surveys. Sixty percent had documented surgical menopause counseling. Patients who were counseled were younger (43 vs 48.5 years, P = 0.005), more likely to have referrals for menopause care (12 vs 9, P = 0.036), more likely to have menopause providers other than oncology providers (14 vs 8, P = 0.001), and had fewer comorbidities. Decreasing age at surgery increased odds of counseling. Most reported continued menopause symptoms and quality of life disturbances. Half were satisfied with menopause care. Majority preferred counseling from oncology providers. Most providers always counseled on surgical menopause but cited lack of time as the primary obstacle for complete counseling.
CONCLUSIONS: Younger age at surgery increased odds of receiving surgical menopause counseling. Gynecologic cancer patients experienced significant menopause-related disturbances. Improved understanding of patient and provider preferences and greater emphases on surgical menopause and survivorship will improve care for gynecologic oncology patients.
Copyright © 2022 by The North American Menopause Society.

Entities:  

Mesh:

Year:  2022        PMID: 35905470      PMCID: PMC9346950          DOI: 10.1097/GME.0000000000002011

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   3.310


  17 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 2.  Management of menopausal symptoms in women with gynecologic cancers.

Authors:  Marcela G Del Carmen; Laurel W Rice
Journal:  Gynecol Oncol       Date:  2017-06-16       Impact factor: 5.482

Review 3.  Managing menopausal symptoms after cancer: an evidence-based approach for primary care.

Authors:  Jennifer L Marino; Helen C McNamara; Martha Hickey
Journal:  Med J Aust       Date:  2018-02-19       Impact factor: 7.738

4.  What information do healthcare professionals need to inform premenopausal women about risk-reducing salpingo-oophorectomy?

Authors:  Martha Hickey; Ines Rio; Alison Trainer; Jennifer L Marino; C David Wrede; Michelle Peate
Journal:  Menopause       Date:  2020-01       Impact factor: 2.953

Review 5.  Factors associated with counseling and postoperative hormone therapy use in surgically menopausal women.

Authors:  Lauren Verrilli; Heidi Brown; Makeba Williams
Journal:  Menopause       Date:  2020-08       Impact factor: 2.953

6.  The REDCap consortium: Building an international community of software platform partners.

Authors:  Paul A Harris; Robert Taylor; Brenda L Minor; Veida Elliott; Michelle Fernandez; Lindsay O'Neal; Laura McLeod; Giovanni Delacqua; Francesco Delacqua; Jacqueline Kirby; Stephany N Duda
Journal:  J Biomed Inform       Date:  2019-05-09       Impact factor: 6.317

7.  Measurement properties of patient-reported outcome measures (PROMs) for women with genitourinary syndrome of menopause: a systematic review.

Authors:  Michaela Gabes; Helge Knüttel; Petra Stute; Christian J Apfelbacher
Journal:  Menopause       Date:  2019-11       Impact factor: 2.953

8.  Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical practice statement: This practice statement has been endorsed by The North American Menopause Society.

Authors:  A K Sinno; J Pinkerton; T Febbraro; N Jones; N Khanna; S Temkin; D Iglesias; B Pothuri
Journal:  Gynecol Oncol       Date:  2020-02-15       Impact factor: 5.482

9.  Hormone Replacement Therapy Prescription after Premature Surgical Menopause.

Authors:  Nisha Garg; Sadikah Behbehani; Heidi Kosiorek; Megan Wasson
Journal:  J Minim Invasive Gynecol       Date:  2020-03-13       Impact factor: 4.137

10.  Patient Satisfaction with Physician Discussions of Treatment Impact on Fertility, Menopause and Sexual Health among Pre-menopausal Women with Cancer.

Authors:  Maura Scanlon; Anne Blaes; Melissa Geller; Navneet S Majhail; Bruce Lindgren; Tufia Haddad
Journal:  J Cancer       Date:  2012-05-16       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.